Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

By G. Schuurhuis, M. Heuser, S. Freeman, M. Béné, F. Buccisano, J. Cloos, D. Grimwade, T. Haferlach, R. Hills, C. Hourigan and 14 more. Blood, 2018

933 citations recorded by the source corpus.

Subfields: Cancer Research, Genetics, Hematology

View Paper: https://www.semanticscholar.org/paper/fac71f6f77c7ede989863daec8bed50168b6aa31